Johnson Matthey (LON:JMAT – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Jefferies Financial Group in a research note issued on Tuesday,Digital Look reports. They presently have a GBX 2,330 target price on the stock. Jefferies Financial Group’s target price would suggest a potential upside of 11.80% from the stock’s previous close.
Other equities research analysts have also issued reports about the company. UBS Group reissued a “neutral” rating and set a GBX 2,200 target price on shares of Johnson Matthey in a report on Friday, May 22nd. Berenberg Bank raised their target price on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research report on Monday, June 1st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 2,400 price target on shares of Johnson Matthey in a research note on Monday, July 6th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Johnson Matthey has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,283.33.
View Our Latest Stock Analysis on JMAT
Johnson Matthey Stock Up 5.3%
Johnson Matthey (LON:JMAT – Get Free Report) last issued its quarterly earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share for the quarter. Johnson Matthey had a negative net margin of 0.76% and a negative return on equity of 4.66%. The firm had revenue of GBX 1,257.30 billion for the quarter. Sell-side analysts expect that Johnson Matthey will post 173.4112903 earnings per share for the current fiscal year.
Insider Buying and Selling at Johnson Matthey
In other Johnson Matthey news, insider Richard Pike purchased 14 shares of the firm’s stock in a transaction dated Wednesday, June 10th. The shares were purchased at an average cost of GBX 1,990 per share, with a total value of £278.60. Also, insider Liam Condon purchased 4,500 shares of the stock in a transaction that occurred on Monday, June 1st. The shares were acquired at an average price of GBX 2,127 per share, for a total transaction of £95,715. In the last three months, insiders bought 11,482 shares of company stock valued at $24,691,314. Corporate insiders own 0.58% of the company’s stock.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
